September 27, 2018
PAFSC’s drug safety panel meeting on Sept. 25 ASKA Pharmaceutical’s generic valsartan might cause cancer in one in 15,000-30,000 patients, if given a 160 mg tablet, the maximum dose, once daily for four years, according to a risk assessment, the...read more